CHARACTERIZATION OF INDUCED NEUROENDOCRINE LUNG CANCER
CHARACTERIZATION OF INDUCED NEUROENDOCRINE LUNG CANCER
批准号:
3191899
负责人:
Hildegard M. Schuller
金额:
$17.07万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1995-01-31
关键词:
bombesin calcitonin cell transformation chemical carcinogen chemical carcinogenesis clone cells disease /disorder model environment related neoplasm /cancer gene expression hamsters hyperoxia lung neoplasms molecular oncology neoplasm /cancer genetics neoplastic transformation neuroendocrine system nicotine nicotinic receptors nitrosamines nucleic acid hybridization polymerase chain reaction preneoplastic state protooncogene radioimmunoassay receptor binding receptor expression respiratory epithelium tumor suppressor genes
中文摘要
神经内分泌型肺癌是人类最常见的癌症之一。
并表明吸烟与吸烟有很强的联系。我们有
建立了第一个也是唯一一个体内神经内分泌癌模型
通过将仓鼠同时施加到与高氧和烟草相关的
亚硝胺。这一新的系统允许研究
这种致命疾病的发生和发展
预防和治疗的策略。
在NIH资助的过去三年的研究中,我们有
其病理、发病机制和神经内分泌学特征
仓鼠神经内分泌肺肿瘤的详细信息,我们已经开发出
从两个这样的肿瘤中获得连续的细胞系。我们提供了令人信服的
有证据表明,在肿瘤起始阶段,刺激
烟碱型胆碱能受体在分子水平上起着至关重要的作用。
导致细胞持续增殖的机制。此外,我们有
研究表明,ras家族癌基因在肿瘤中过表达。
和细胞系。
利用仓鼠模型和这些肿瘤细胞系,我们将在
详细说明烟碱型胆碱能受体在该阶段的分子作用
肿瘤的启动和该受体的调节
进步。此外,我们还将对仓鼠肿瘤和细胞系进行筛选
用于相关癌基因的表达和突变
人类和啮齿动物肺癌。随后,我们将在
这些基因表达的变化发生在什么肿瘤的发展阶段
以及这与已有文献记载的发病阶段有何关系?
神经内分泌标志物的调节。在今年的第三年
继续项目,然后我们将开始探索关联
在基因表达的改变和细胞周期蛋白的功能调节之间
烟碱胆碱能受体。
我们的数据与人类神经内分泌肺癌和
将为这一疾病的防治提供有意义的依据。
常见的肺癌类型。
英文摘要
Neuroendocrine lung cancer is among the most common cancers of mankind
and demonstrates a strong association with cigarette smoking. We have
developed the first and only in vivo model of neuroendocrine ling cancer
by imposing hamsters simultaneously to hyperoxia and tobacco-related
nitrosamines. This novel system allows to study the mechanisms of
initiation and progression of this deadly disease and to develop
strategies for its prevention and therapy.
During the past three years of NIH-funded research, we have
characterized the pathology, pathogenesis, and neuroendocrinology of the
hamster neuroendocrine lung tumors in detail, and we have developed
continuous cell lines from two such tumors. We have provided convincing
evidence that during the stage of tumor initiation, stimulation of
nicotinic cholinergic receptors play a crucial role in the molecular
mechanisms which cause continuous cell proliferation. Moreover, we have
shown that overexpression of ras-family oncogenes is found in the tumors
and cell lines.
Using the hamster model and these tumor cell lines, we will study in
detail the molecular role f nicotinic cholinergic receptors at the stage
of tumor initiation and the modulation of this receptor during
progression. Moreover, we will screen the hamster tumors and cell lines
derived from them for the expression and mutation of oncogenes pertinent
to human and rodent lung cancers. Subsequently, we will determine at
what stag of tumor development these changes in gene expression occur
and how this relates to the already documented stages of pathogenesis
and modulations in neuroendocrine markers. During the third year of this
continuation project, we will then begin to explore the association
between alterations in gene expression and functional modulations of the
nicotinic cholinergic receptor .
Our data are highly relevant to human neuroendocrine lung cancer and
will provide a meaningful basis for the prevention and therapy of this
common lung cancer type.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The GABA-B receptor is a novel drug target for pancreatic cancer
-
批准号:8064258
-
项目类别:
-
资助金额:$26.45万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
Modulation of cancer prevention by social stress
-
批准号:7809021
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
-
批准号:8252196
-
项目类别:
-
资助金额:$26.45万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
-
批准号:7714157
-
项目类别:
-
资助金额:$27.27万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
Modulation of cancer prevention by social stress
-
批准号:7937956
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
-
批准号:7872882
-
项目类别:
-
资助金额:$27.27万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
Preclin. model for prevention of NSCLC in former smokers
-
批准号:6613046
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2003
-
负责人:Hildegard M. Schuller
-
依托单位:
Preclin. model for prevention of NSCLC in former smokers
-
批准号:6744372
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2003
-
负责人:Hildegard M. Schuller
-
依托单位:
Preclin. model for prevention of NSCLC in former smokers
-
批准号:6895771
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2003
-
负责人:Hildegard M. Schuller
-
依托单位:
Preclin. model for prevention of NSCLC in former smokers
-
批准号:7285066
-
项目类别:
-
资助金额:$3.16万
-
财政年份:2003
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK, Beta-Adrenergic AA Release and Lung Cancer
-
批准号:6721254
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2002
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK, Beta-Adrenergic AA Release and Lung Cancer
-
批准号:6874971
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2002
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK, Beta-Adrenergic AA Release and Lung Cancer
-
批准号:6470444
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2002
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK, Beta-Adrenergic AA Release and Lung Cancer
-
批准号:6623847
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2002
-
负责人:Hildegard M. Schuller
-
依托单位:
FACS VANTAGE SE CELL SORTER/FLOW CYTOMETER
-
批准号:6053811
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2000
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
-
批准号:2094195
-
项目类别:
-
资助金额:$19.12万
-
财政年份:1994
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
-
批准号:2467272
-
项目类别:
-
资助金额:$6.46万
-
财政年份:1994
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
-
批准号:2094196
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1994
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
-
批准号:2094197
-
项目类别:
-
资助金额:$20.8万
-
财政年份:1994
-
负责人:Hildegard M. Schuller
-
依托单位:
MECHANISMS OF NEUROENDOCRINE LUNG CARCINOGENESIS
-
批准号:3509571
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1991
-
负责人:Hildegard M. Schuller
-
依托单位:
国内基金
海外基金
降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)对穴位敏化的调节及机制研究
-
批准号:81873385
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:乔海法
-
依托单位: